Zanolimumab, the promising pharmaceutical drug, represents a significant advance in immunotherapy . It functions as this humanized protein, specifically engineered to bind with the CD4 molecule expressed on T helper immune entities. This attachment causes more info to a reduction in CD4 pathway , po